BioLife Solutions Expands Scientific Advi...( Adds Cell Therapy Regulatory Cons...)

Adds Cell Therapy Regulatory Consultant and Cryopreservation Expert

BOTHELL, Wash., Sept. 5 /PRNewswire-FirstCall/ -- BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced the expansion of its Scientific Advisory Board (SAB) with the addition of two leading experts in cell therapy quality and regulatory assurance and in cryopreservation of stem cells derived from cord blood, dental pulp, and other sources.

The new members are:

-- Scott R. Burger, MD - Principal of Advanced Cell and Gene Therapy, a

consulting firm specializing in cell, gene, and tissue-based therapies.

Dr. Burger works with clients in industry and academic centers

worldwide, providing assistance in process development and validation,

GMP/GTP manufacturing, GMP facility design and operation, regulatory

affairs, technology evaluation, and strategic analysis. He received his

M.D. from the University of Pennsylvania School of Medicine and

completed postgraduate training in Laboratory Medicine and a clinical

fellowship in Transfusion Medicine and a postdoctoral research

fellowship at Washington University in St. Louis. He serves on the USP

Cell, Gene and Tissue Therapies Expert Committee, the advisory boards

of several cell therapy biotechnology companies, and has served as

editor of the International Society for Cellular Therapy Telegraft, and

on the ISCT Executive Committee. A frequently invited speaker at

industry and academic conferences, he is the author of more than 100

scientific publications and presentations, and recipient of numerous

honors and awards.

-- Erik J. Woods, Ph.D. - Co-Founder, CEO and Laboratory Director of The

Genesis Bank, a private cord blood bank,
'/>"/>